• Explore /
  • Poster
  • / Efficacy, safety, and immune activation with pegylated human IL-10 (AM0010) in combination with an anti-PD1 in advanced NSCLC.

Efficacy, safety, and immune activation with pegylated human IL-10 (AM0010) in combination with an anti-PD1 in advanced NSCLC.

Abstract Poster

Authors

null

Deborah Jean Lee Wong

David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA

Deborah Jean Lee Wong , Jeffrey Gary Schneider , Raid Aljumaily , Wolfgang Michael Korn , Jeffrey R. Infante , Manish R. Patel , Karen A. Autio , Kyriakos P. Papadopoulos , Aung Naing , Nashat Y. Gabrail , Pamela N. Munster , Jonathan Wade Goldman , Peter Van Vlasselaer , Gail Linda Brown , Annie Hung , Martin Oft , Edward B. Garon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT02009449

Citation

J Clin Oncol 35, 2017 (suppl; abstr 9091)

DOI

10.1200/JCO.2017.35.15_suppl.9091

Abstract #

9091

Poster Bd #

417

Abstract Disclosures

Similar Posters

Poster

2016 ASCO Annual Meeting

Clinical activity and safety of pegylated human IL-10 (AM0010) in combination with anti-PD1.

Clinical activity and safety of pegylated human IL-10 (AM0010) in combination with anti-PD1.

First Author: Aung Naing

First Author: Aung Naing

First Author: Aung Naing

First Author: Panpan Zhang